Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer.

MLA

Tappero, Stefano, et al. “Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer.” Urologic Oncology, vol. 41, no. 7, July 2023, p. 326.e9-326.e16. EBSCOhost, https://doi.org/10.1016/j.urolonc.2023.01.015.

APA

Tappero, S., Barletta, F., Piccinelli, M. L., Cano Garcia, C., Incesu, R.-B., Morra, S., Scheipner, L., Tian, Z., Parodi, S., Dell’Oglio, P., Briganti, A., de Cobelli, O., Chun, F. K. H., Graefen, M., Mirone, V., Ahyai, S., Saad, F., Shariat, S. F., Suardi, N., … Karakiewicz, P. I. (2023). Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer. Urologic Oncology, 41(7), 326.e9-326.e16. https://doi.org/10.1016/j.urolonc.2023.01.015

Chicago

Tappero, Stefano, Francesco Barletta, Mattia Luca Piccinelli, Cristina Cano Garcia, Reha-Baris Incesu, Simone Morra, Lukas Scheipner, et al. 2023. “Adenocarcinoma of the Bladder: Assessment of Survival Advantage Associated With Radical Cystectomy and Comparison With Urothelial Bladder Cancer.” Urologic Oncology 41 (7): 326.e9-326.e16. doi:10.1016/j.urolonc.2023.01.015.